U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07400952) titled 'Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus' on Feb. 03.
Brief Summary: Multi-center, parallel-group, placebo-controlled trial designed to assess the safety and efficacy of twice-daily topically administered GLK-221 Ophthalmic Solution in subjects with keratoconus.
Study Start Date: Dec. 23, 2025
Study Type: INTERVENTIONAL
Condition:
Keratoconus
Intervention:
DRUG: GLK-221 Ophthalmic Solution
GLK-221 Ophthalmic Solution administered twice daily to both eyes
DRUG: Placebo Ophthalmic Solution
Placebo Ophthalmic Solution administered twice daily to bo...